Crystallization of urinary calcium oxalate at standardized osmolality and pH in the frozen state.

[1]  M. Gohel,et al.  Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects. , 1993, Clinical science.

[2]  E. Neilson,et al.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Coe,et al.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. , 1989, The American journal of physiology.

[4]  E. Liong,et al.  Demonstration of calcium oxalate crystallization-enhancing activity of urinary macromolecules with a gel model , 1989 .

[5]  W. Robertson,et al.  Modifiers of calcium oxalate crystallization found in urine. II. Studies on their mode of action in an artificial urine. , 1986, The Journal of urology.

[6]  D. Carey,et al.  A cytoskeleton-associated plasma membrane heparan sulfate proteoglycan in Schwann cells. , 1986, The Journal of biological chemistry.

[7]  W. Robertson,et al.  Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine. , 1986, The Journal of urology.

[8]  C. Roehrborn,et al.  Determination of stone-forming risk by measuring crystal formation in whole urine with gel model. , 1986, Urology.

[9]  F. Coe,et al.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. , 1985, The Journal of clinical investigation.

[10]  B. Finlayson,et al.  Mechanisms of stone formation--an overview. , 1984, Scanning electron microscopy.

[11]  E. Kaiser,et al.  Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. , 1983, The Journal of biological chemistry.

[12]  N. Malavolta,et al.  Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion. , 1983, The Journal of urology.

[13]  G. A. Rose,et al.  Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies. , 1982, The Journal of urology.

[14]  C. Samuell.  A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[15]  J. S. Elliot,et al.  Calcium oxalate crystalluria: crystal size in urine. , 1980, The Journal of urology.

[16]  G. A. Rose,et al.  A new urinary test for stone "activity". , 1978, British journal of urology.

[17]  H. Fleisch.  Inhibitors and promoters of stone formation. , 1978, Kidney international.

[18]  M. Peacock,et al.  Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. , 1976, The New England journal of medicine.

[19]  Rosenbaum Mb.  Renal stone formation. The inhibitory effect of urine on calcium oxalate precipitation. , 1975 .

[20]  J. Scott,et al.  The estimation of acid glycosaminoglycan-Alcian blue complexes eluted from electrophoretic strips. , 1974, Analytical biochemistry.

[21]  M. Peacock,et al.  Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[22]  T. Yamagata,et al.  Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. , 1968, The Journal of biological chemistry.

[23]  J. Scott.  Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues. , 2006, Methods of biochemical analysis.